The stock is currently trading at 14.7x and 12.5x CY21E and CY22E EV/EBITDA. We value ACL at 13x CY22E EV/EBITDA. However, owing to a recent run-up in prices, we change our rating from BUY to HOLD.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.